Literature DB >> 16611653

COPD is associated with increased mortality in patients with community-acquired pneumonia.

M I Restrepo1, E M Mortensen, J A Pugh, A Anzueto.   

Abstract

Patients with chronic obstructive pulmonary disease (COPD) who develop community-acquired pneumonia (CAP) may experience worse clinical outcomes. However, COPD is not included as a distinct diagnosis in validated instruments that predict mortality in patients with CAP. The aim of the present study was to evaluate the impact of COPD as a comorbid condition on 30- and 90-day mortality in CAP patients. A retrospective observational study was conducted at two hospitals. Eligible patients had a discharge diagnosis and radiological confirmation of CAP. Among 744 patients with CAP, 215 had a comorbid diagnosis of COPD and 529 did not have COPD. The COPD group had a higher mean pneumonia severity index score (105+/-32 versus 87+/-34) and were admitted to the intensive care unit more frequently (25 versus 18%). After adjusting for severity of disease and processes of care, CAP patients with COPD showed significantly higher 30- and 90-day mortality than non-COPD patients. Chronic obstructive pulmonary disease patients hospitalised with community-acquired pneumonia exhibited higher 30- and 90-day mortality than patients without chronic obstructive pulmonary disease. Chronic obstructive pulmonary disease should be evaluated for inclusion in community-acquired pneumonia prediction instruments.

Entities:  

Mesh:

Year:  2006        PMID: 16611653     DOI: 10.1183/09031936.06.00131905

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  75 in total

1.  Observational study of inhaled corticosteroids on outcomes for COPD patients with pneumonia.

Authors:  Dennis Chen; Marcos I Restrepo; Michael J Fine; Mary Jo V Pugh; Antonio Anzueto; Mark L Metersky; Brandy Nakashima; Chester Good; Eric M Mortensen
Journal:  Am J Respir Crit Care Med       Date:  2011-04-21       Impact factor: 21.405

Review 2.  The Lung Microbiome and Its Role in Pneumonia.

Authors:  Benjamin G Wu; Leopoldo N Segal
Journal:  Clin Chest Med       Date:  2018-12       Impact factor: 2.878

Review 3.  Pathology of human influenza revisited.

Authors:  Thijs Kuiken; Jeffery K Taubenberger
Journal:  Vaccine       Date:  2008-09-12       Impact factor: 3.641

4.  Cigarette Smoke Exposure Promotes Virulence of Pseudomonas aeruginosa and Induces Resistance to Neutrophil Killing.

Authors:  Jason Chien; John H Hwang; Sedtavut Nilaad; Jorge A Masso-Silva; Sae Jeong Ahn; Elisa K McEachern; Alexander Moshensky; Min-Kwang Byun; Laura E Crotty Alexander
Journal:  Infect Immun       Date:  2020-10-19       Impact factor: 3.441

Review 5.  Long-term prognosis in community-acquired pneumonia.

Authors:  Marcos I Restrepo; Paola Faverio; Antonio Anzueto
Journal:  Curr Opin Infect Dis       Date:  2013-04       Impact factor: 4.915

6.  Reactive oxygen species regulate neutrophil recruitment and survival in pneumococcal pneumonia.

Authors:  Helen M Marriott; Laura E Jackson; Thomas S Wilkinson; A John Simpson; Tim J Mitchell; David J Buttle; Simon S Cross; Paul G Ince; Paul G Hellewell; Moira K B Whyte; David H Dockrell
Journal:  Am J Respir Crit Care Med       Date:  2008-01-17       Impact factor: 21.405

7.  Predictors of inhospital mortality and re-hospitalization in older adults with community-acquired pneumonia: a prospective cohort study.

Authors:  Binod Neupane; Stephen D Walter; Paul Krueger; Tom Marrie; Mark Loeb
Journal:  BMC Geriatr       Date:  2010-05-11       Impact factor: 3.921

Review 8.  An overview of the benefits and drawbacks of inhaled corticosteroids in chronic obstructive pulmonary disease.

Authors:  Sonal Singh; Yoon K Loke
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-08-09

9.  Early fiberoptic bronchoscopy during non-invasive ventilation in patients with decompensated chronic obstructive pulmonary disease due to community-acquired-pneumonia.

Authors:  Raffaele Scala; Mario Naldi; Uberto Maccari
Journal:  Crit Care       Date:  2010-04-29       Impact factor: 9.097

Review 10.  Influenza infection and COPD.

Authors:  Patrick Mallia; Sebastian L Johnston
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.